- Home
- VATE vs ALGS Comparison
VATE vs ALGS Comparison
Compare VATE & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- ALGS
- Stock Information
- Founded
- VATE 1994
- ALGS 2018
- Country
- VATE United States
- ALGS United States
- Employees
- VATE N/A
- ALGS N/A
- Industry
- VATE Metal Fabrications
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- VATE Industrials
- ALGS Health Care
- Exchange
- VATE Nasdaq
- ALGS Nasdaq
- Market Cap
- VATE 65.1M
- ALGS 53.0M
- IPO Year
- VATE 1996
- ALGS 2020
- Fundamental
- Price
- VATE $5.69
- ALGS $11.34
- Analyst Decision
- VATE
- ALGS Strong Buy
- Analyst Count
- VATE 0
- ALGS 2
- Target Price
- VATE N/A
- ALGS $60.00
- AVG Volume (30 Days)
- VATE 22.6K
- ALGS 74.9K
- Earning Date
- VATE 11-05-2025
- ALGS 11-05-2025
- Dividend Yield
- VATE N/A
- ALGS N/A
- EPS Growth
- VATE N/A
- ALGS N/A
- EPS
- VATE N/A
- ALGS N/A
- Revenue
- VATE $995,000,000.00
- ALGS $3,174,000.00
- Revenue This Year
- VATE N/A
- ALGS N/A
- Revenue Next Year
- VATE N/A
- ALGS $28.79
- P/E Ratio
- VATE N/A
- ALGS N/A
- Revenue Growth
- VATE N/A
- ALGS N/A
- 52 Week Low
- VATE $3.25
- ALGS $3.76
- 52 Week High
- VATE $13.79
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- VATE 58.49
- ALGS 70.84
- Support Level
- VATE $4.98
- ALGS $10.01
- Resistance Level
- VATE $5.72
- ALGS $10.86
- Average True Range (ATR)
- VATE 0.39
- ALGS 0.97
- MACD
- VATE 0.11
- ALGS 0.13
- Stochastic Oscillator
- VATE 97.27
- ALGS 90.81
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.